Effects of Blood Collection Conditions on Ovarian Cancer Serum Markers
Author Information
Author(s): Jason D. Thorpe, Xiaobo Duan, Robin Forrest, Kimberly Lowe, Lauren Brown, Elliot Segal, Brad Nelson, Garnet L. Anderson, Martin McIntosh, Nicole Urban
Primary Institution: Fred Hutchinson Cancer Research Center
Hypothesis
The environment and conditions of sample collection can affect the levels of biomarkers, introducing potential biases in biomarker validation study design.
Conclusion
Prolactin levels are strongly influenced by blood collection conditions, while CA 125 and MIF are not, suggesting the need for standardized collection conditions in biomarker validation studies.
Supporting Evidence
- Prolactin levels were significantly affected by blood collection conditions.
- CA 125 and MIF levels were not significantly affected by the conditions of blood collection.
- Standardized collection conditions are necessary for accurate biomarker validation.
Takeaway
This study shows that how and when blood is collected can change the results of cancer tests, so it's important to collect samples in the same way for accurate results.
Methodology
Serum concentrations of CA 125, Prolactin, and MIF were analyzed in various groups of women, with samples collected under different conditions.
Potential Biases
Potential biases due to differences in blood collection conditions between cases and controls.
Limitations
The study may not account for all variables affecting biomarker levels, and the sample size for some control groups was small.
Participant Demographics
Participants included healthy women, women with ovarian cancer, and women undergoing surgery for benign conditions.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website